Skye Bioscience (SKYE) Non Operating Income (2012 - 2026)

Skye Bioscience (SKYE) has reported Non Operating Income for 12 consecutive years, with $278109.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Income fell 55.32% year-over-year to $278109.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 57.0% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 38.27% from the prior year.
• Non Operating Income was $278109.0 for Q2 2026 at Skye Bioscience, up from $165005.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $1.1 million in Q1 2024 and troughed at -$2.1 million in Q1 2023.
• A 5-year average of $125210.9 and a median of $221557.0 in 2026 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income plunged 3490.84% in 2022 and jumped 545.91% in 2024, its largest moves.
• Over 5 years, Non Operating Income stood at -$606972.0 in 2022, then soared by 45.03% to -$333673.0 in 2023, then surged by 375.61% to $919622.0 in 2024, then sank by 50.68% to $453581.0 in 2025, then sank by 38.69% to $278109.0 in 2026.
• The last three Non Operating Income figures came in at $278109.0 (Q2 2026), $165005.0 (Q1 2026), and $453581.0 (Q4 2025), per Business Quant data.